Introduction
Dopamine receptors are G protein-coupled receptors (GPCRs). These receptors can be divided into D 1 -like and D 2 -like families. D 2 receptors belong to the D 2 -like family. The activation of D 2 R reduces cAMP expression [1] , extracellular signalregulated kinase1/2 (ERK) phosphorylation [2] , phospholipase C activation [3] , and receptor internalization [4] [5] [6] . Adenosine receptors are also GPCRs [7] . Dopamine D 2 and Adenosine A 2a receptors form heterodimers [8] [9] [10] . In D 2 Rcotransfected neuroblastoma cells, long-term exposure to A 2a R and D 2 R agonists resulted in the co-aggregation, co-internalization, and co-desensitization of A 2a R and D 2 R [9] . However, the modulation of D 2 R downstream signaling and internalization through A 2a R has not been fully demonstrated.
The A 2a R antagonist has been demonstrated to improve the Modulation of A 2a receptor antagonist on D 2 receptor internalization and ERK phosphorylation effects of L-dopa and to reduce "off" time in clinical trials [11] [12] [13] . Because dopamine receptors play a key role in Parkinson's disease [14] , characterizing the modulation of D 2 R downstream signaling through A 2a R would increase our understanding of the role of D 2 R/A 2a R heterodimers in Parkinson's disease.
In the present study, we explored the ability of the A 2a R antagonist ZM241385 in A 2a R/D 2 R cotransfected cells and striatal neurons to attenuate the receptor internalization and ERK phosphorylation induced by the D 2 R agonist quinpirole; we also demonstrated the participation of Src kinase and β-arrestin in D 2 R internalization and ERK phosphorylation.
Materials and methods
Primary striatal neurons culture Dissociated primary cultures of striatal neurons from embryonic d 18 (E18) rats were prepared from timed-pregnant Sprague Dawley rats as described previously, with minor modifications [15] . Briefly, the fetuses were removed under sterile conditions and maintained on iced D-Hank's solution for microscopic dissection of the striatum. The meninges were removed. The tissue was briefly minced and triturated using a fire-polished Pasteur pipette. The cells were counted and plated on six-well culture plates in DMEM containing 10% fetal bovine serum (FBS). After 5 h, the medium was replaced with serum-free B27/neurobasal medium supplemented with 0.5 mmol/L glutamine and antibiotics. The cultures were maintained at 37 ºC in a humidified 5% CO 2 atmosphere.
HEK293 cell culture HEK293 cells were cultured at 37 °C and 5% CO 2 in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% FBS.
Co-immunoprecipitation and immunoblotting
Cell lysates were prepared after incubation in modified radioimmunoprecipitation assay (RIPA) lysis buffer (Tris-HCl 50 mmol/L, pH 7.4, 150 mmol/L NaCl, 1 mmol/L EDTA, 0.25% Na-deoxycholate, 1% NP-40, 1 mmol/L PMSF, 1 mmol/L Na 3 VO 4 , 1 mmol/L NaF, 10 μg/mL aprotinin, 5 μg/mL leupeptin, and 5 μg/mL pepstatin). The clarified lysates were subjected to SDS-PAGE and electrophoretically transferred to PVDF membranes as described previously [15] . The blots were incubated overnight at 4 °C with primary antibodies. After probing with horseradish peroxidase-conjugated secondary antibodies for 1 h at room temperature, the immunoreactive proteins were visualized using an enhanced chemiluminescence kit (Pierce, Rockford, Illinois, USA). In some cases, the blots were stripped and reprobed with other antibodies.
Interactions between D 2 R and β-arrestin or A 2a R were examined by coimmunoprecipitation. Briefly, the cells were prepared after incubation in Tx/G lysis buffer (300 mmol/L NaCl, 1% Triton X-100, 10% glycerol, 1.5 mmol/L MgCl 2 , 1 mmol/L CaCl 2 , 10 mmol/L EDTA and 50 mmol/L Tris, pH 7.4) containing 100 mmol/L iodoacetamide, 10 μg/mL aprotinin and 5 μg/mL leupeptin for 45 min on ice [16] . The clarified lysates were immunoprecipitated through overnight incubation at 4 °C using anti-D 2 R (Millipore, Bedford, MA, USA) or anti-A 2a R antibodies (Millipore, Bedford, MA, USA), followed by incubation with Protein A/G-Sepharose beads (Santa Cruz, CA, USA). Equivalent amounts of protein were analyzed for each condition. The beads were washed three times with lysis buffer, and the immune complexes were boiled in SDS sample buffer and loaded onto SDS-PAGE gels for immunoblot analysis. The immunoreactive protein bands were detected using the enhanced chemiluminescence kit (Pierce, Rockford, Illinois, USA).
Biotinylation assays
Living striatal neurons or HEK293 cells were labeled for 20 min at 37 °C with EZ-link NHS-SS-biotin (300 μg/mL, Pierce, Rockford, Illinois, USA) to biotinylate the surface proteins [17] . After washing in PBS+MC, the cells were incubated in medium alone or medium containing different compounds for various times. Trafficking was terminated after rapid cooling to 4 °C. The biotinylated proteins remaining on the cell surface were stripped of biotin using the non-permeant reducing agent glutathione (150 mmol/L glutathione and 150 mmol/L NaCl, pH 8.75). Glutathione was subsequently neutralized with 50 mmol/L iodoacetamide in PBS+MC. The cells were incubated in RIPA buffer (50 mmol/L Tris, pH 7.4, 150 mmol/L NaCl, 1 mmol/L EDTA, 1% SDS) for 30 min at 4 °C. After centrifugation at 16 000×g, supernatants containing equal amounts of total protein were incubated with streptavidin beads overnight at 4 °C to capture biotinylated proteins. After washing in extraction buffer, the samples were boiled in sample buffer to elute the biotinylated proteins from the streptavidin beads. The proteins were separated by SDS-PAGE and immunoblotted using antibodies against D 2 R (1:600), A 2a R (1:4000, Millipore Bedford, MA, USA) or Myc (1:1000 Cell Signaling Technology, Beverly, MA, USA). The immunoblots were processed using a standard chemiluminescence protocol. Equal amount of proteins untreated with streptavidin beads were used for normalization.
Fluorescence internalization assay HEK293 cells co-transfected with D 2 GFP/A 2a RFP were first treated for 1 h with the indicated compounds, after which they were fixed with 4% paraformaldehyde (PFA). Fluorescence images were acquired using confocal microscopy (Olympus, Lake Success, NY, USA) and quantified with Image Pro Plus. Total fluorescence intensities (a) and cytoplasmic fluorescence intensities (b) were quantified separately. The percentage of cell surface protein was quantified as (a-b)/a×100%.
Immunofluorescence
Primary cultured striatal neurons were fixed with acetone, and after washing twice with PBS, the cells were blocked for 1 h in blocking buffer (5% normal goat serum and 1% BSA in PBS) before incubation with anti-D 2 R and anti-A 2a R antibodies diluted in blocking buffer at 4 °C overnight. The cells were washed three times with PBS and incubated with Alexa Fluor 488 conjugated goat anti-rabbit IgG and Alexa Fluor 555 conjugated goat anti-mouse IgG (1:100) (Molecular probes, Eugene, OR, USA) for 1.5 h at room temperature. The images were captured using a confocal microscope (Olympus, Lake Success, NY, USA).
BRET assay
The plasmids were transfected into HEK293 cells. At 48 h after transfection, the culture medium was removed, and the cells were washed twice with PBS and subsequently resuspended in DPBS at a density of 3. 
Plasmid construction
Prof Jerrey L BENOVIC (Thomas Jefferson University) kindly provided β-arrestin (319-418). A 1 R-pcDNA3.1 was generated in our lab [18] . The other constructs were produced by PCR using specific primers. For D 2 GFP, the D 2 R fragments were generated by PCR, ligated into the expression vector pCDNA3.1 (Invitrogen, Carlsbad, CA, USA), and sequenced. The primers used were forward 5'-CCAAGCTTGCCAC-CATGGATCCACTGAATCTGTCCTGGT-3' and reverse 5'-CCGGAATTCTCAGCAGTGGAGGATCTTCAGGA-3'.
The amplified fragments were fluorescently tagged at the carboxyl terminus using GFP. For D 2 Myc, the same D 2 R fragment was generated by PCR using the same primers and inserted into pcDNA3.1/myc-His A (Invitrogen, Carlsbad, CA, USA). For A 2a RFP, the A 2a R fragment was generated by PCR, ligated into the expression vector pcDNA3.1 (Invitrogen, Carlsbad, CA, USA), and sequenced. The primers used were forward 5'-CGGAATTCATGCCCATCATGGGCTCCTC-3' and reverse 5'-GCTCTAGACTACAGCTCGTCCATGC-CGA-3'. The amplified fragments were fluorescently tagged at the carboxyl terminus using RFP. Prof Jing-gen LIU (Shanghai Institute of Materia Medica, Chinese Academic of Science) kindly provided pGFP2-N3 and pRluc-N3. For D2pGFP2-N3, the D 2 R fragment was generated by PCR, ligated into the expression vector pGFP2-N3, and sequenced. The primers used were forward 5'-CCGGAATTCATGGATC-CACTGAATCTGTCCTGGT-3' and reverse 5'-CCAAGCTTG-CAGTGGAGGATCTTCAGGAAGGCCTTG-3'. For A 2a Rluc-N3, the A 2a R fragment was generated by PCR, ligated into the expression vector pRluc-N3, and sequenced. The forward and reverse primers were 5'-CCCTCGAGATGCCCAT-CATGGGCTCCTC-3' and 5'-CCAAGCTTGGACACTCCT-GCTCCATCCT-3', respectively.
Statistics
The data were presented as the means±SEM and compared with one-way ANOVA followed by the Bonferroni post hoc test using the GraphPad InStat statistical program. The level of statistical significance was set at P<0.01 and P<0.05. The data were obtained from at least three separate experiments.
Results
D 2 R and A 2a R form heterodimers D 2 R and A 2a R were highly expressed on striatopallidal neurons. To confirm the interaction between D 2 R and A 2a R, immunofluorescence experiments were performed using primary cultured striatal neurons. The results showed that D 2 R and A 2a R were co-localized on striatal neurons ( Figure  1A ). The co-immunoprecipitation results indicated that D 2 R and A 2a R formed complexes on striatal neurons ( Figure 1B) . Furthermore, the BRET assay demonstrated that D 2 R and A 2a R formed heterodimers on HEK293 cells ( Figure 1C ). These results suggested that D 2 R and A 2a R co-localize and form heterodimers. Quinpirole-induced internalization is attenuated upon combined treatment with ZM241385 and quinpirole The long-term activation of D 2 R could lead to D 2 R internalization [6] . Internalization is important for regulating GPCR downstream signaling. A biotinylation assay and confocal microscopy were used to investigate the modulation of the A 2a R agonist or antagonist on D 2 R internalization. DIV 9 striatal neurons were treated with the A 2a R agonist CGS21680 or the D 2 R agonist quinpirole alone or in combination for 3 h, and the subsequent induction of A 2a R and D 2 R co-internalization were observed (Figure 2A, 2B) . Because A 2a R and D 2 R form heterodimers, the activation of either the D 2 or A 2a receptor could induce the co-internalization of D 2 R/A 2a R heterodimers, consistent with previously reported data [9] . The results also showed that the A 2a receptor antagonist ZM241385 reduced D 2 receptor internalization ( Figure 2C ).
To further confirm this result, the effects of A 2a R on D 2 R internalization were also examined in HEK293 cells. Plasmids carrying D 2 GFP and A 2a RFP were co-transfected into HEK293 cells. After treatment with different compounds, the cells were fixed with 4% paraformaldehyde, and images were captured using confocal microscopy (Olympus). The results showed that treatment with CGS21680 or quinpirole, separately or in combination, induced the co-internalization of the two receptors. In addition, ZM241385 reduced D 2 R quinpirole-induced internalization (Figure 3) , consistent with the result obtained using striatal neurons. D 2 R internalization occurs in a β-arrestin/clathrin-and Src kinase-dependent manner Src kinase and β-arrestin are important for GPCR internalization. We used a surface biotinylation assay to characterize the role of Src kinase in D 2 R internalization. The results showed that striatal neurons treated with PP2, an Src kinase inhibitor, obviously inhibited quinpirole-induced D 2 R internalization ( Figure 4A ), suggesting that D 2 R internalization is Src kinase dependent.
Many GPCRs are internalized in a β-arrestin/clathrindependent manner. The dominant negative β-arrestin (319-418) mutant was used to determine the roles of β-arrestins in D 2 R internalization. This plasmid inhibited β-arrestin/clathrin-dependent receptor internalization through blocking the formation of the β-arrestin/clathrin complex [19] . We treated β-arrestin (319-418)-transfected HEK293 cells with the D 2 R agonist quinpirole to detect D 2 R internalization using Western blotting. The results showed that the expression of β-arrestin (319-418) in HEK293 cells inhibited quinpirole-induced D 2 R internalization, thereby demonstrating that β-arrestin was involved in D 2 R internalization ( Figure 4B ). These results were consistent with previously reported data [2, 4, 6] .
ZM241385 reduced D 2 R-induced Src kinase phosphorylation and β-arrestin 2 recruitment
Because Src kinase is involved in D 2 R internalization, this protein might also participate in the ZM241385-mediated modulation of D 2 R internalization. We used Western blotting to determine whether Src plays a role in the internalization of A 2a R and D 2 R. The results indicated that the activation of D 2 R induces Src kinase phosphorylation in striatal neurons. ZM241385 also attenuated D 2 R-induced Src kinase phosphorylation ( Figure 5A) .
Moreover, the co-immunoprecipitation data showed that activated D 2 R recruited β-arrestin 2 to striatal neurons and that ZM241385 reduced D 2 R and β-arrestin 2 interactions ( Figure  5B ).
These results demonstrated that both Src kinase and β-arrestin are involved in D 2 R internalization and that ZM241385 reduces D 2 R-induced Src kinase phosphorylation 
ZM241385 reduced D 2 R-induced ERK phosphorylation
Extracellular regulated protein kinases (ERK1/2) are members of the mitogen-activated protein kinase (MAPK) family, which are involved in many important events, such as neuron survival and cell differentiation [4] . The activation of D 2 R induces ERK phosphorylation [20] . Thus, the roles of A 2a R/D 2 R heterodimerization in D 2 R-induced ERK activation were also investigated.
Western blot analysis showed that the activation of A 2a R did not affect D 2 R-induced ERK phosphorylation ( Figure 6A ), whereas ZM241385 reduced D 2 R-induced ERK phosphorylation in a dose-dependent manner ( Figure 6B ). These results were confirmed in HEK293 cells ( Figure 6D ).
Src kinase and β-arrestin participated in D 2 R-induced ERK phosphorylation when D 2 R was co-expressed with A 2a R D 2 R induces ERK activation in a G protein-dependent manner, and Src kinase participates in this activation [2, 4] . However, the mechanism of ERK activation might be different under different conditions. The formation of heterodimers might affect receptor-induced ERK activation [21] . In some cases, signal proteins, such as β-arrestin, not only participate in receptor inter- www.chinaphar.com Huang L et al Acta Pharmacologica Sinica npg nalization but also are involved in ERK activation [22, 23] . Striatal neurons were treated with the Src kinase-specific inhibitor PP2, followed by treatment with the D 2 R agonist quinpirole. PP2 inhibited quinpirole-induced ERK phosphorylation (Figure 7) , suggesting that Src kinase is involved in D 2 R-induced ERK phosphorylation, consistent with previously [2] . Some studies have implicated β-arrestin in mechanisms of the GPCR downstream signaling pathway, such as ERK phosphorylation [21, 22, 24] . The mutant β-arrestin (319-418) was used to investigate effects of β-arrestins in D 2 receptor-induced ERK activation. The data showed that in HEK 293 cells expressing D 2 R alone, the expression of β-arrestin (319-418) did not affect quinpirole-induced ERK phosphorylation ( Figure 8A ), consistent with previous reports [20] . Interestingly, in HEK293 cells co-expressing D 2 R and A 2a R, the expression of β-arrestin (319-418) attenuated quinpirole-induced ERK phosphorylation ( Figure 8B ), whereas β-arrestin (319-418) expression in HEK293 cells co-expressing D 2 R and A 1 R did not affect quinpirole-induced ERK phosphorylation ( Figure 8C ). These results suggested that D 2 R/A 2a R heterodimerization changed D 2 R-induced ERK phosphorylation.
Taken together, these results showed that Src kinase ( Figure  7 ) and β-arrestin (Figure 8 The present study also demonstrated that after activation, D 2 R is internalized through a β-arrestin/clathrin-dependent pathway involving Src kinase. Western blot analysis revealed that ZM241385 reduces D 2 R-induced Src kinase phosphorylation, and co-immunoprecipitation showed that ZM241385 reduces the D 2 R-mediated recruitment of β-arrestin2. These results indicated that ZM241385 reduces D 2 R-induced Src kinase phosphorylation and the recruitment of β-arrestin2, thereby reducing D 2 R internalization. Fuxe et al demonstrated that A 2a R activation enhances D 2 R binding with β-arrestin2 and that D 2 R, A 2a R, and β-arrestin2 might form a complex [25] . In the present study, we showed that ZM241385 reduces the D 2 R-mediated recruitment of β-arrestin2. Thus, it is possible that A 2a R is involved in the interaction of β-arrestin2 and D 2 R/ A 2a R heterodimers. ZM241385 maintains A 2a R in an inactive status [26, 27] and affects the interaction between D 2 R/A 2a R het- erodimer and β-arrestin2, thereby reducing D 2 R internalization. Clinical studies have shown that the A 2a R antagonist prolongs the effective time and shortens the "off time" of L-dopa [11, 28] , potentially reflecting D 2 R internalization. In this study, we showed that the A 2a R antagonist reduces D 2 R-induced Src kinase phosphorylation and β-arrestin2 recruitment; thus, the A 2a R antagonist might not only reduce D 2 R internalization but also modulate D 2 R downstream signaling. The results in the present study also showed that D 2 Rinduced ERK activation is Src kinase dependent. Moreover, the expression of the mutant β-arrestin (319-418) also reduced D 2 R-induced ERK activation when D 2 R was co-expressed with A 2a R, suggesting that both Src kinase and β-arrestin participate in D 2 R-induced ERK activation. The A 2a R antagonist reduces D 2 R-induced Src kinase phosphorylation and β-arrestin2 recruitment; thus, the A 2a R antagonist might also reduce D 2 Rinduced ERK activation.
Interestingly, β-arrestin was also involved in D 2 R-induced ERK phosphorylation when D 2 R was co-expressed with A 2a R, but not when D 2 R was expressed alone. ERK phosphorylation might be influenced by many factors, and receptor dimerization might also influence ERK activation [21] . To our knowledge, most studies on D 2 R-induced ERK activation have utilized cells expressing D 2 R alone, showing that the expression of β-arrestin (319-418) had no effects on D 2 R-induced ERK activation [20] ; these results were also confirmed in the present study. However, when D 2 R and A 2a R were co-expressed, β-arrestin participated in D 2 R-induced ERK activation. In vivo, particularly in the striatum, D 2 R exists not only as a monomer or homodimer but also as a D 2 R/A 2a R heterodimer [9] . Thus, the results of the present study enhance the current understanding of the mechanism underlying D 2 R-induced ERK activation under physiological conditions. Different mechanisms of ERK activation might exert different downstream effects. Distinguishing D 2 R monomer-induced ERK phosphorylation from D 2 R/A 2a R heterodimer-induced ERK activation is difficult, as the development of a system containing only D 2 R/ A 2a R receptor heterodimers and no D 2 R monomers is not easy. However, this study showed the importance of heterodimers in receptor downstream signaling pathway.
Thus, this study showed that D 2 R and A 2a R co-internalize. The A 2a R antagonist reduced D 2 R-induced Src kinase phosphorylation and β-arrestin2 recruitment, thereby reducing D 2 R internalization and ERK phosphorylation. These observations showed that D 2 R/A 2a R heterodimers play an important role in D 2 R signaling pathway and trafficking.
